EUVIMEDEUVIMED entdecken
Crossref

A chemiluminescent imaging immunosensor based on copper-doped NiFe PBA nanozyme for detection of BTN3A2: A candidate biomarker in early stage of gastric cancer

Lulu Zhao, Maoying Peng, Chunmei Liu, Feng Shi, Hui Chen, Guiling Li, Ming Yang, Zhanjun Yang, Chuanli Ren

Biosensors and Bioelectronics · 2026-08 · 305 · 118681

DOI: 10.1016/j.bios.2026.118681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-08. Verfasst von Lulu Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China; Department of Labor…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Biosensing Techniques, Butyrophilins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Jiangsu Commission of Health, Jiangsu Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The early diagnosis of gastric cancer (GC) faces great challenges due to the lack of specific biomarkers. Therefore, it is crucial to discover effective markers and establish highly sensitive detection methods. This study validated the potential of BTN3A2 protein as an early GC biomarker by analyzing serum samples from patients with GC, benign gastritis, other digestive system cancers, and healthy controls across three clinical centers. Furthermore, a chemiluminescent (CL) imaging immunosensor based on copper-doped NiFe PBA (Cu-NiFe PBA) nanozyme probe was developed to achieve highly sensitive detection of BTN3A2 protein in serum of patients with GC and healthy controls. The high detection sensitivity for BTN3A2 was achieved by copper doping to enhance peroxidase-like activity of nanozyme for signal amplification. The proposed sensor exhibits a broad linear range from 0.5 to 5000 pg/mL, and achieves a detection limit of 0.15 pg/mL (S/N = 3). In addition, the established sensor is successfully utilized for BTN3A2 detection in serum samples from GC and healthy individuals across three clinical centers, and demonstrates perfect correlation with clinical outcomes when compared with traditional enzyme-linked immunosorbent assay. This study provides a candidate serum biomarker in the early stage of GC and offers a convenient, highly sensitive method for its detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorBiosensing TechniquesButyrophilinsHumansLuminescent MeasurementsCopperLimit of DetectionImmunoassayEarly Detection of Cancer

Stichwörter der Autor:innen

BTN3A2BiomarkerChemiluminescenceEarly gastric cancerNanozyme

Substanzen

Biomarkers, TumorCopperButyrophilins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China; Department of Laboratory Medicine, Yizheng People's Hospital, Yangzhou, 211400, China.
  • School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, 225002, China.
  • Department of Laboratory Medicine, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China.
  • College of Pharmacy, Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, 563003,…
  • Department of Geriatrics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, No. 98 Western Nantong Road, Yangzhou, 225001, China.
  • Department of Laboratory Medicine, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China. Electronic address: liguiling728@163.com.

Förderung

  • Jiangsu Commission of Health
  • Jiangsu Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, L., Peng, M., Liu, C., Shi, F., Chen, H., Li, G., Yang, M., Yang, Z., & Ren, C. (2026). A chemiluminescent imaging immunosensor based on copper-doped NiFe PBA nanozyme for detection of BTN3A2: A candidate biomarker in early stage of gastric cancer. Biosensors and Bioelectronics, 305, 118681. https://doi.org/10.1016/j.bios.2026.118681

Vancouver

Zhao L, Peng M, Liu C, Shi F, Chen H, Li G, et al. A chemiluminescent imaging immunosensor based on copper-doped NiFe PBA nanozyme for detection of BTN3A2: A candidate biomarker in early stage of gastric cancer. Biosensors and Bioelectronics. 2026;305:118681. doi:10.1016/j.bios.2026.118681

BibTeX
@article{Zhao2026,
  author = {Zhao, Lulu and Peng, Maoying and Liu, Chunmei and Shi, Feng and Chen, Hui and Li, Guiling and Yang, Ming and Yang, Zhanjun and Ren, Chuanli},
  title = {A chemiluminescent imaging immunosensor based on copper-doped NiFe PBA nanozyme for detection of BTN3A2: A candidate biomarker in early stage of gastric cancer},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {305},
  pages = {118681},
  doi = {10.1016/j.bios.2026.118681}
}
Kostenlos starten →